Catalyst Wire Dossier Catalyst Wire Dossier

Tipranavir (Aptivus)

tipranavir · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tipranavir (Aptivus), covering 2014-09-25 to 2014-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir [Phase 2]

See pricing